Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Aurora Cannabis Inc (NASDAQ: ACB) closed at $4.34 up 2.84% from its previous closing price of $4.22. In other words, the price has increased by $2.84 from its previous closing price. On the day, 1.28 million shares were traded. ACB stock price reached its highest trading level at $4.43 during the session, while it also had its lowest trading level at $4.28.
Ratios:
For a deeper understanding of Aurora Cannabis Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.63 and its Current Ratio is at 3.41. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.07.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACB now has a Market Capitalization of 245536800 and an Enterprise Value of 285930432. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.32. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.94 while its Price-to-Book (P/B) ratio in mrq is 0.64. Its current Enterprise Value per Revenue stands at 0.779 whereas that against EBITDA is -85.942.
Stock Price History:
The Beta on a monthly basis for ACB is 0.32, which has changed by -0.06866956 over the last 52 weeks, in comparison to a change of 0.14778805 over the same period for the S&P500. Over the past 52 weeks, ACB has reached a high of $6.91, while it has fallen to a 52-week low of $3.42. The 50-Day Moving Average of the stock is -6.93%, while the 200-Day Moving Average is calculated to be -10.56%.
Shares Statistics:
For the past three months, ACB has traded an average of 1.84M shares per day and 2864700 over the past ten days. A total of 56.58M shares are outstanding, with a floating share count of 56.39M. Insiders hold about 0.55% of the company’s shares, while institutions hold 17.10% stake in the company. Shares short for ACB as of 1765756800 were 7042933 with a Short Ratio of 3.83, compared to 1763078400 on 6976983.
Earnings Estimates
A detailed examination of Aurora Cannabis Inc (ACB) is currently in progress, with 1.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $0.05, with high estimates of $0.05 and low estimates of $0.05.
Analysts are recommending an EPS of between $0.05 and -$1.12 for the fiscal current year, implying an average EPS of -$0.71. EPS for the following year is $0.11, with 3.0 analysts recommending between $0.36 and -$0.36.
Revenue Estimates
A total of 4 analysts believe the company’s revenue will be $92.42M this quarter.It ranges from a high estimate of $93.6M to a low estimate of $90.8M. As of. The current estimate, Aurora Cannabis Inc’s year-ago sales were $88.2MFor the next quarter, 4 analysts are estimating revenue of $98.95M. There is a high estimate of $103.3M for the next quarter, whereas the lowest estimate is $96.6M.
A total of 4 analysts have provided revenue estimates for ACB’s current fiscal year. The highest revenue estimate was $385.3M, while the lowest revenue estimate was $377M, resulting in an average revenue estimate of $379.9M. In the same quarter a year ago, actual revenue was $343.29MBased on 3 analysts’ estimates, the company’s revenue will be $400.47M in the next fiscal year. The high estimate is $410.6M and the low estimate is $384.8M.
